SUPERNUS PHARMACEUTICALS, INC. (SUPN) Form 10-Q Quarterly Reports
SUPERNUS PHARMACEUTICALS, INC. (SUPN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SUPN
CIK: 1356576
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerHugh Mohler
Audit LocationBaltimore, Maryland, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001356576-26-000040 | View SEC Doc Filr Page |
| 425 | 2026-10-06 | — | 425 | 0001104659-26-113884 | View SEC Doc Filr Page |
| DEFA14A | 2026-10-06 | — | DEFA14A | 0001104659-26-113882 | View SEC Doc Filr Page |
| DEFM14A | 2026-09-11 | — | DEFM14A | 0001104659-26-107109 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001539937-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001836067-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001539215-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001804567-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001194020-26-000015 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0001104659-26-092198 | View SEC Doc Filr Page |
| 425 | 2026-08-04 | — | 425 | 0001193125-26-331036 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001193125-26-330875 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-03 | — | DEFA14A | 0001104659-26-089849 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001104659-26-089848 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | FORM 8-K | 0001104659-26-089839 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-03 | — | DEFA14A | 0001104659-26-089526 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001104659-26-089525 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | FORM 8-K | 0001104659-26-089524 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001356576-26-000037 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001356576-26-000035 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-03 | — | DEFA14A | 0001104659-26-089427 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001104659-26-089426 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-01 | FORM 8-K | 0001104659-26-089425 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | FORM 4 | 0001539937-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | FORM 4 | 0001194020-26-000013 | View SEC Doc Filr Page |